These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4366262)

  • 1. Proceedings: Urinary hydroxyproline and leucocyte ascorbic acid levels in patients bearing breast tumour with skeletal metastases.
    Basu TK; Raven RW; Williams DC
    Ann R Coll Surg Engl; 1974 Jun; 54(6):273-4. PubMed ID: 4366262
    [No Abstract]   [Full Text] [Related]  

  • 2. Leucocyte ascorbic acid and urinary hydroxyproline levels in patients bearing breast cancer with skeletal metastases.
    Basu TK; Raven RW; Dickerson JW; Williams DC
    Eur J Cancer (1965); 1974 Aug; 10(8):507-11. PubMed ID: 4463001
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary hydroxyproline in the elderly with low leucocyte ascorbic acid levels.
    Windsor AC; Williams CB
    Br Med J; 1970 Mar; 1(5698):732-3. PubMed ID: 5440550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascorbic acid supplementation and five year survival rates in women with early breast cancer.
    Poulter JM; White WF; Dickerson JW
    Acta Vitaminol Enzymol; 1984; 6(3):175-82. PubMed ID: 6524577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Variable behavior of urinary hydroxyproline in breast cancer with osseous metastases].
    Polico C; Nascimben O; Maccari F; Fazzin G
    Quad Sclavo Diagn; 1978 Dec; 14(4):486-93. PubMed ID: 757622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the relationship between Hess tests and leucocyte ascorbic acid in a clinical trial.
    Eddy TP
    Br J Nutr; 1972 May; 27(3):537-42. PubMed ID: 5031180
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical picture of bone metabolism in breast cancer patients with bone metastases.
    Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A
    Anticancer Res; 1995; 15(6B):2871-5. PubMed ID: 8669881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific vitamin deficiencies and their significance in patients with cancer and receiving chemotherapy.
    Dickerson JW; Basu TK
    Curr Concepts Nutr; 1977; 6():95-104. PubMed ID: 604020
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast cancer].
    Ditzel J; Jordal R; Riskoer N
    Ugeskr Laeger; 1968 Oct; 130(42):1766-71. PubMed ID: 5724711
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary hydroxyproline excretion and vitamin C status in healthy young men.
    Hevia P; Omaye ST; Jacob RA
    Am J Clin Nutr; 1990 Apr; 51(4):644-8. PubMed ID: 2321570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The leucocyte ascorbic acid levels of children in hospital.
    Dawson KP; Richardson WW; Orsborn CE
    N Z Med J; 1977 Feb; 85(582):141-3. PubMed ID: 266652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: Urinary hydorxyproline excretion in the monitoring of carcinoma of the breast.
    Lester E
    Br J Radiol; 1976 Mar; 49(579):290. PubMed ID: 1276611
    [No Abstract]   [Full Text] [Related]  

  • 13. [Urinary hydroxyproline in advanced breast carcinoma and response to treatment with medroxyprogesterone acetate (MAP) in high doses].
    Martoni A; Pedelini G; Colalongo G; Biagi R; Mambelli M; Jafelice G; Rocchetta G; Piana E; Pannuti F
    Minerva Med; 1980 Sep; 71(31):2215-9. PubMed ID: 7422143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leucocyte ascorbic acid in abnormal leucocyte states.
    Barton GM; Roath OS
    Int J Vitam Nutr Res; 1976; 46(3):271-4. PubMed ID: 977212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucocyte ascorbic acid concentration and plasma ascorbic acid levels in children with various infections.
    Tanzer F; Ozalp I
    Mater Med Pol; 1993; 25(1):5-8. PubMed ID: 8412344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary hydroxyproline excretion in patients with breast cancer.
    Cuschieri A; Felgate R
    Br J Surg; 1971 Nov; 58(11):862. PubMed ID: 5124876
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma and leucocyte ascorbic acid concentrations in acute lymphoblastic leukaemia.
    Kakar SC; Wilson CW; Bell JN
    Ir J Med Sci; 1975 Jun; 144(6):227-32. PubMed ID: 1056315
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxyproline and zinc excretion in patients with neoplastic breast disease.
    Percudani M; Dell'Anna B; De Lorenzis GF; Ferraccioli GF; Vaona GL
    Int Surg; 1981; 66(3):233-6. PubMed ID: 7319736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Leucocyte ascorbic acid in abnormal leucocyte states.
    Barton GM; Roath OS
    J Clin Pathol; 1976 Jan; 29(1):86. PubMed ID: 1249260
    [No Abstract]   [Full Text] [Related]  

  • 20. 'Early' breast cancer, bone scanning, and the urinary excretion of hydroxyproline.
    Sumner DS; Baum M; Parsons V; Edwards MH
    Br J Surg; 1973 Apr; 60(4):306. PubMed ID: 4700234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.